Activation of MYC, a bona fide client of HSP90, contributes to intrinsic ibrutinib resistance in mantle cell lymphoma.
Lee J, Zhang LL, Wu W, Guo H, Li Y, Sukhanova M, Venkataraman G, Huang S, Zhang H, Alikhan M, Lu P, Guo A, Galanina N, Andrade J, Wang ML, Wang YL.
Lee J, et al.
Blood Adv. 2018 Aug 28;2(16):2039-2051. doi: 10.1182/bloodadvances.2018016048.
Blood Adv. 2018.
PMID: 30115641
Free PMC article.